Accelevation Holdings Corp. priced its initial public offering at $18.00 a share for 30,000,000 shares of Class A common stock, with the announcement made on Sept. 29, 2026.
For retail traders, the key point is that the company is not selling all of the stock itself: 10,000,000 shares are being offered by Accelevation and 20,000,000 shares by certain selling stockholders affiliated with Olympus Partners.
The underwriters also have a 30-day option to buy up to another 4,500,000 shares at the IPO price, less underwriting discounts and commissions.
The shares are expected to begin trading on The Nasdaq Global Select Market on Sept. 30, 2026 under the ticker ACCV, and the offering is expected to close on Oct. 1, 2026, subject to customary closing conditions.
Accelevation says it intends to use the net proceeds from the offering to buy newly issued units in Accelevation Holdings LLC, while Accelevation Holdings LLC intends to use the balance it receives to repay indebtedness, pay offering-related and certain organizational expenses, and for general corporate purposes.
Accelevation said it will not receive any of the proceeds from the sale of shares by the selling stockholders.
Morgan Stanley and J.P. Morgan are acting as joint lead bookrunning managers, while Goldman Sachs & Co. LLC, Barclays and BofA Securities are joint bookrunning managers. Houlihan Lokey, Baird, William Blair, Piper Sandler and Wolfe | Nomura Alliance are additional bookrunners.
Highlights
- The offering covers 30,000,000 shares of Class A common stock at $18.00 each.
- 10,000,000 shares are being sold by Accelevation and 20,000,000 by selling stockholders affiliated with Olympus Partners.
- The shares are expected to trade on The Nasdaq Global Select Market under the ticker ACCV on Sept. 30, 2026.
